Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples